IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Jagsonpal Pharmaceuticals

NSE:JAGSNPHARM · ISIN INE048B01035

Close
Unavailable
Date unavailable
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Jagsonpal Pharmaceuticals

Ratings & risks

Credit signals

Rating-action history

Agency evidence
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Ratings withdrawnICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Ratings reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Long-term rating reaffirmed and short-term rating upgraded to [ICRA]A2ICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Ratings reaffirmed; outlook revised to PositiveICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Update on Material EventICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Ratings upgraded to [ICRA]BBB (Stable)/A3+ICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Ratings reaffirmed; outlook revised to PositiveICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Ratings upgraded to [ICRA]BBB- (Stable)/[ICRA]A3ICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: [ICRA]BB+(Stable)/A4+ reaffirmedICRA Limited · discovered
Agency source
ICRA Limited · Jagsonpal Pharmaceuticals Limited: Update on Material EventICRA Limited · discovered
Agency source
ICRA Limited · ICRA reaffirms ratings of ICRA]BB+ and [ICRA]A4+ on bank facilities of Jagsonpal Pharmaceuticals LimitedICRA Limited · discovered
Agency source
Risk research framework

Questions to test against evidence

Analyst review
Operating deterioration

Track sector-specific operating metrics and reconcile them across reporting periods.

High
Funding and liquidity

Review debt maturity, repricing, liquidity and rating commentary where relevant.

High
Execution versus guidance

Compare management statements with subsequent reported delivery.

Medium
Governance and key-person change

Connect management transitions, related parties and auditor observations.

Medium